uclagrades.com

MCD BIO 168: Stem Cell Biology

State-of-art education of embryonic and adult stem cells and how these pluripotent/multipotent cells can be used to treat congenital defects, diseases, or injury in humans. Review of current knowledge of human and mouse embryonic stem cells and how they develop into various tissue types. Discussion of adult stem cells in hematopoietic, nervous, and other organ systems to provide examples of tissue-specific stem cells and their impact in human disease. Examination of various model organisms as examples of how model organisms have helped to discover fundamental principles in stem cell biology. How advances in cell and molecular biology and tissue engineering can be applied to use of stem cells in regenerative medicine. Ethical and legal issues related to stem cell research.

5 units, lecture, discussion

Loading...

HANNA K A MIKKOLAWinter 20268394.0% (78)

A-range % and grade counts cover only each instructor’s latest recorded term, shown in the "Latest Data From" column, combining all sections for the course. A-range % is the share of recorded letter grades (A+ through F) that are A+, A, or A−. Parentheses show the A-range count over the total letter-grade count. P/NP and incompletes are excluded. Records may be incomplete.

Available Academic Terms
Winter 2022 · Winter 2023 · Winter 2024 · Winter 2026

This website is not affiliated with UCLA. Grade distribution data from 2021–2022 was sourced through a February 2023 public records request made under the California Public Records Act. 40+ UCLA students paid $131.25 to obtain these records. Grade distribution data from 2022–2023 and 2024–2025 were sourced similarly.

UCLA students can download the data on Google Drive (log into your UCLA Google Account to access): Fall 2021–Summer 2022, Fall 2022–Spring 2023, Summer 2023–Spring 2024, Summer 2024–Spring 2025, Summer 2025–Fall 2025, Winter 2026–Spring 2026

Source code for this site is on GitHub; contributions are welcome and appreciated. Questions, comments, bug reports, and feature requests are welcome at this link.